1. D‐dimer as a predictor of venous thromboembolism in acutely ill, hospitalized patients: a subanalysis of the randomized controlled MAGELLAN trial. (April 2014) Authors: Cohen, A. T.; Spiro, T.E.; Spyropoulos, A. C.; DeSanctis, Y. H.; Homering, M.; Büller, H. R.; Haskell, L.; Hu, D.; Hull, R.; Mebazaa, A.; Merli, G.; Schellong, S.; Tapson, V. F.; Burton, P. Journal: Journal of thrombosis and haemostasis Issue: Volume 12:Number 4(2014:Apr.) Page Start: 479 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Rivaroxaban for thromboprophylaxis among patients recently hospitalized for acute infectious diseases: a subgroup analysis of the MAGELLAN study. (21st June 2018) Authors: Cohoon, K. P.; De Sanctis, Y.; Haskell, L.; McBane, R. D.; Spiro, T. E. Journal: Journal of thrombosis and haemostasis Issue: Volume 16:Number 7(2018) Page Start: 1278 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗